As of 2025-05-13, the Fair Value of Kiniksa Pharmaceuticals Ltd (KNSA) is -2.96 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 26.84 USD, the upside of Kiniksa Pharmaceuticals Ltd is -111.03%.
With the market price of 26.84 USD and our fair value calculation, Kiniksa Pharmaceuticals Ltd (KNSA) is not a good investment. Investing in KNSA stocks now will result in a potential loss of 111.03%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -161.38 | -157.92 | 183.36 | 14.08 | -43.19 | -33.01 |
| YoY growth | 0.30% | 2.14% | 216.11% | -92.32% | -406.68% | -56.09% |
| Market Cap (mil) | 1,958.51 |
| P/E | |
| Forward P/E |
| EPS | -0.59 |
| Avg earnings growth rate | -56.09% |
| TTM earnings | -43.19 |